Follow
Pran Kishore Deb
Pran Kishore Deb
Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi
Verified email at bitmesra.ac.in
Title
Cited by
Cited by
Year
Synthesis, anti-inflammatory evaluation and docking studies of some new fluorinated fused quinazolines
C Balakumar, P Lamba, D Pran Kishore, BL Narayana, KV Rao, ...
European journal of medicinal chemistry 45 (11), 4904-4913, 2010
2132010
Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer
M Shubhangi, P Abhimanyu, K Kaushik, M Rahul, D Pran Kishore, K Kiran, ...
International Journal of Pharmaceutics 584 (1), 540-558, 2018
145*2018
Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents
D Aakash, KB Richa, K Ramanjot, K Sanjiv, KJ Upendra, S Harinder, ...
Current Topics in Medicinal Chemistry 17 (2), 238-250, 2017
1392017
Thiazole: A versatile standalone moiety contributing to the development of various drugs and biologically active agents
MF Arshad, A Alam, AA Alshammari, MB Alhazza, IM Alzimam, MA Alam, ...
Molecules 27 (13), 3994, 2022
1062022
Pharmaceutical and biomedical applications of polymers
D Pran Kishore, SF Kokaz, SN Abed, A Paradkar, RK Tekade
Basic Fundamentals of Drug Delivery, 203-267, 2019
1012019
Molecular dynamics simulation strategies for designing carbon-nanotube-based targeted drug delivery
AQ Mohammed N, D Pran Kishore, T Rakesh K.
Drug Discovery Today 23 (2), 235-250, 2018
1012018
ADMET profiling in drug discovery and development: perspectives of in silico, in vitro and integrated approaches
NEH Daoud, P Borah, PK Deb, KN Venugopala, W Hourani, M Alzweiri, ...
Current Drug Metabolism 22 (7), 503-522, 2021
802021
Three-dimensional in vitro cell culture models for efficient drug discovery: Progress so far and future prospects
SM Badr-Eldin, HM Aldawsari, S Kotta, PK Deb, KN Venugopala
Pharmaceuticals 15 (8), 926, 2022
702022
Protein/peptide drug delivery systems: practical considerations in pharmaceutical product development
D Pran Kishore, O Al-Attraqchi, B Chandrasekaran, A Paradkar, ...
Basic Fundamentals of Drug Delivery, 651-684, 2019
672019
Neurological consequences of SARS-CoV-2 infection and concurrence of treatment-induced neuropsychiatric adverse events in COVID-19 patients: navigating the uncharted
P Borah, PK Deb, B Chandrasekaran, M Goyal, M Bansal, S Hussain, ...
Frontiers in molecular biosciences 8, 627723, 2021
612021
Synthesis, anti-inflammatory evaluation, and docking studies of some new thiazole derivatives
D Pran Kishore, R Kaur, B Chandrasekaran, M Bala, D Gill, VR Kaki, ...
Medicinal Chemistry Research 23 (6), 2780-2792, 2014
592014
Exploring the potential of carbon dots to combat COVID-19
S Kotta, HM Aldawsari, SM Badr-Eldin, NA Alhakamy, S Md, AB Nair, ...
Frontiers in molecular biosciences 7, 616575, 2020
582020
Selective COX-2 inhibitors: road from success to controversy and the quest for repurposing
AA El-Malah, MM Gineinah, PK Deb, AN Khayyat, M Bansal, ...
Pharmaceuticals 15 (7), 827, 2022
542022
QSAR of adenosine receptor antagonists: exploring physicochemical requirements for binding of pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives with human …
D Pran Kishore, C Balakumar, AR Rao, PP Roy, K Roy
Bioorganic & medicinal chemistry letters 21 (2), 818-823, 2011
522011
Medicinal chemistry and therapeutic potential of agonists, antagonists and allosteric modulators of A1 adenosine receptor: Current status and perspectives
D Pran Kishore, S Deka, P Borah, SN Abed, KN Klotz
Current pharmaceutical design 25 (25), 2697-2715, 2019
502019
Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors
D Pran Kishore, A Sharma, P Piplani, RR Akkinepally
Molecular diversity 16, 803-823, 2012
492012
Cytotoxicity and Antimycobacterial Properties of Pyrrolo [1, 2-a] quinoline Derivatives: Molecular Target Identification and Molecular Docking Studies
KN Venugopala, V Uppar, S Chandrashekharappa, HH Abdallah, M Pillay, ...
Antibiotics 9 (5), 233, 2020
482020
Current advances in the clinical development of anti-tubercular agents
SR Tetali, E Kunapaeddi, RP Mailavaram, V Singh, P Borah, PK Deb, ...
Tuberculosis 125, 101989, 2020
452020
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme
KN Venugopala, S Chandrashekharappa, PK Deb, C Tratrat, M Pillay, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1471-1486, 2021
442021
Dendrimer-based nanocarriers in lung Cancer therapy
B Gorain, H Choudhury, M Pandey, AB Nair, MCIM Amin, N Molugulu, ...
Nanotechnology-based targeted drug delivery systems for lung cancer, 161-192, 2019
432019
The system can't perform the operation now. Try again later.
Articles 1–20